Bipolar Disorder News

Antipsychotic treatment did not increase risk for mortality among adults with serious mental illness diagnosed with COVID-19 infection, according to study results in a research letter published in JAMA Psychiatry.

Patients with PTSD or bipolar disorder reported significant improvement with consultation of primary care physicians or treatment by telepsychiatrists, according to a JAMA Psychiatry study.

Several factors increased risk for stimulant treatment discontinuation and switch to nonstimulants among people with ADHD, according to study results published in American Journal of Psychiatry.

The FDA has approved an olanzapine/samidorphan combination treatment for schizophrenia and bipolar 1 disorder in adults.

Most patients with bipolar disorder endorsed involuntary treatment via self-binding directives on the basis of impaired decision-making abilities, according to study results published in The Lancet Psychiatry.

Psychiatric conditions were associated with a younger age at onset of Alzheimer’s disease, and age differences only grew with each additional psychiatric diagnosis, researchers reported.

While the prevalence of chronic kidney disease is higher in patients with severe mental illness compared with the general population, limited research has made it difficult for staff to detect key markers of mental illness, a speaker said.

Bright light therapy appeared efficacious as a treatment for bipolar depression, according to a presenter at the American Psychiatric Association’s annual meeting.

The early portion of the COVID-19 pandemic led to ‘dramatic changes’ in psychiatric care, which were primarily linked to the rapid transition to telehealth care, according to study results published in Journal of Clinical Psychiatry.

Adults with severe mental illness and diabetes need more intensive interventions and greater support to overcome barriers to diabetes self-management, according to a study published in Diabetic Medicine.